Amgen Articles
Graffinity in research deal with Amgen
5 March 2007
Safety concerns linked to Aranesp in cancer trial
26 February 2007
Bush administration accused of "power grab"
12 February 2007
Fresenius in new deal with Amgen
12 February 2007
Stock Commentary - New York week to Jan 29, 2007
5 February 2007
Wyeth's income up 17%, but shares fall 2.5%
5 February 2007
Amgen UK appointment
5 February 2007
Stock Commentary - New York week to Aug 15
29 January 2007
NICE recommends Mimpara with caveats
29 January 2007
Stock Commentary - New York week to Jan 15, 2007
22 January 2007
Stock Commentary - New York week to Jan 8, 2007
15 January 2007
Cytokinetics/Amgen enter R&D accord
15 January 2007
Galapagos expands drug discovery collaboration with Amgen
8 January 2007
RA biological competitors spent $195M on promotion
8 January 2007
Galapagos to buy ProSkelia for $16.5M
22 December 2006
Ph IIIb study shows benefits of extended Aranesp dosing
22 December 2006
November a lackluster month for biotechnology stocks, says Burrill
18 December 2006
Wyeth updates on UK roll out of Enbrel PFS
18 December 2006
Amgen responds to anemia drug controversy
11 December 2006
Amgen names Yuri Orihara president of Japanese subsidiary
11 December 2006
Stock Commentary - New York week to Nov 27
4 December 2006
Medarex expects Amgen milestone from UltiMAb deal
20 November 2006
Amgen presents Ph IV data on Enbrel
20 November 2006
UK regulator gives nod to Amgen's Mimpara
13 November 2006
Biotech takeovers gather pace, reaching a record level
13 November 2006
Study: Procrit cheaper than rival anemia drugs
6 November 2006
US court denies Roche's motion to dismiss Amgen's law suit
30 October 2006
Amgen completes Avidia acquisition
30 October 2006
Wyeth's income climbs 33% to $1.16B in 3rd-qtr, on continued success of Enbrel and Prevnar
30 October 2006
Stock Commentary - New York week to Oct 16, 2006
23 October 2006
Hana Biosci in-licenses menadione
23 October 2006
FDA requests more data on Amgen's Aranesp
23 October 2006
Amgen's Kevin Sharer is new president of PhRMA
16 October 2006
Enbrel demonstrates long-term safety profile
16 October 2006
Stock Commentary - Europe - week to Oct 2, 2006
9 October 2006
FDA clears Amgen's cancer drug Vectibix
9 October 2006
Amgen to buy Avidia for $290M + $90M
9 October 2006
Memory Pharma gets milestone from Amgen
9 October 2006
Enbrel launched in prefilled syringes UK
9 October 2006
Amgen appoints Thomas Flanagan as senior VP and CIO
2 October 2006
Amgen's Denosumab MAb effective in trial
2 October 2006
New board chairman for PhRMA
25 September 2006
Biotech stocks in holding pattern for August, says Burrill report
18 September 2006
Blockbuster status forecast for Enbrel by 2010
18 September 2006
Big Pharma needs to catch up with specialty detailing
18 September 2006
ITC will not review initial verdict in Roche case
11 September 2006
Split patent decison for Amgen and Shire
14 August 2006
Stock Commentary - New York week to Aug 7, 2006
7 August 2006
Pliva and Mayne amend G-CSF deal
7 August 2006
Amgen's 2nd-qtr 2006 sales up 14% to $3.6B
31 July 2006
J&J's record 2nd-qtr 2006 sales boost profit 10%
24 July 2006
Stock Commentary - New York week to July 10, 2006
17 July 2006
Amgen to terminate 'poison pill'
17 July 2006
ITC judge rules peg-EPO covered by exemption
17 July 2006
Amgen sees $1B profits in 1st-qtr 2006
24 April 2006
DPI signs merger deal with Inifinity
24 April 2006
Four vice president appointments at Genentech
17 April 2006
Amgen files with ITC to stop Roche's peg-EPO imports
17 April 2006
Amgen's pantiumumab sees strong Ph III data
17 April 2006
Amgen completes acquisition of Abgenix
10 April 2006
Amgen/Abgenix submit cancer MAb BLA to FDA
3 April 2006
Abgenix' shareholder OK takeover by Amgen
3 April 2006
Amgen to explore anemia in CV patients
20 March 2006
Amgen initiates debt sale, stock buyback
20 February 2006
Amgen/Biovitrum expand diabetes deal
20 February 2006
Stock Commentary - New York week to Feb 6
13 February 2006
Amgen starts $1B Puerto Rico site expansion
13 February 2006
Roche delays CERA US FDA filing, Amgen gains
13 February 2006
Stock Commentary - New York week to Jan 30
6 February 2006
Wyeth moves into profit but disapoints
6 February 2006
Pharma/biotech mergers and acquisitions during 2005
6 February 2006
Amgen and Genentech deal on antibody patents
30 January 2006
US cancer therapy market to grow 10% pa through 2009
30 January 2006
Amgen announces investments in Europe
30 January 2006
ImClone up for sale as it returns to profit
30 January 2006
Hawaii Biotech gets $7.8M financing
16 January 2006
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
